Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
If you want to clean up, then look at the hygiene trend -- and these numbers from Reckitt Benckiser and Procter & Gamble.
I'm starting to believe the legacy automakers may be the best way to play the EV space in 2021.
MSFT has been a key stock in the tech rally but it has behaved differently since early September.